Newly Discovered Epidermal Growth Factor Receptor Active In Human Pancreatic Cancers

Finally some promising news about pancreatic cancer, one of the most fatal cancers, due to the difficulties of early detection and the lack of effective therapies: Scientists have identified an epidermal growth factor receptor aberrantly active in approximately a third of the 250 human pancreatic cancers studied.

Read the whole article on Science Daily

More from Science Daily